These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 28011475

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway-Driven Intestinal Neoplasia.
    Georgescu MM, Gagea M, Cote G.
    Neoplasia; 2016 Aug; 18(8):512-23. PubMed ID: 27566107
    [Abstract] [Full Text] [Related]

  • 7. Na+-H+ exchanger regulatory factor 1 (NHERF1) PDZ scaffold binds an internal binding site in the scavenger receptor megalin.
    Slattery C, Jenkin KA, Lee A, Simcocks AC, McAinch AJ, Poronnik P, Hryciw DH.
    Cell Physiol Biochem; 2011 Aug; 27(2):171-8. PubMed ID: 21325834
    [Abstract] [Full Text] [Related]

  • 8. Phosphorylation of NHERF1 S279 and S301 differentially regulates breast cancer cell phenotype and metastatic organotropism.
    Greco MR, Bon E, Rubino R, Guerra L, Bernabe-Garcia M, Cannone S, Cayuela ML, Ciaccia L, Marionneau-Lambot S, Oullier T, Fromont G, Guibon R, Roger S, Reshkin SJ, Cardone RA.
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):26-37. PubMed ID: 30326259
    [Abstract] [Full Text] [Related]

  • 9. Regulation of expression and function of scavenger receptor class B, type I (SR-BI) by Na+/H+ exchanger regulatory factors (NHERFs).
    Hu Z, Hu J, Zhang Z, Shen WJ, Yun CC, Berlot CH, Kraemer FB, Azhar S.
    J Biol Chem; 2013 Apr 19; 288(16):11416-35. PubMed ID: 23482569
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. NHERF1/EBP50 is a new marker in colorectal cancer.
    Hayashi Y, Molina JR, Hamilton SR, Georgescu MM.
    Neoplasia; 2010 Dec 19; 12(12):1013-22. PubMed ID: 21170265
    [Abstract] [Full Text] [Related]

  • 12. NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway.
    Gu Y, Yu H, Hao C, Martin TA, Hargest R, He J, Cheng S, Jiang WG.
    Oncotarget; 2017 Jan 31; 8(5):7753-7765. PubMed ID: 27999191
    [Abstract] [Full Text] [Related]

  • 13. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
    Cheng S, Li Y, Yang Y, Feng D, Yang L, Ma Q, Zheng S, Meng R, Wang S, Wang S, Jiang WG, He J.
    FEBS Lett; 2013 Oct 11; 587(20):3289-95. PubMed ID: 24012959
    [Abstract] [Full Text] [Related]

  • 14. Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer.
    Shen J, Cao B, Wang Y, Ma C, Zeng Z, Liu L, Li X, Tao D, Gong J, Xie D.
    J Exp Clin Cancer Res; 2018 Jul 28; 37(1):175. PubMed ID: 30055645
    [Abstract] [Full Text] [Related]

  • 15. Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling.
    Wheeler DS, Barrick SR, Grubisha MJ, Brufsky AM, Friedman PA, Romero G.
    Oncogene; 2011 Jan 06; 30(1):32-42. PubMed ID: 20802536
    [Abstract] [Full Text] [Related]

  • 16. The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2.
    Jeong J, VanHouten JN, Kim W, Dann P, Sullivan C, Choi J, Sneddon WB, Friedman PA, Wysolmerski JJ.
    J Biol Chem; 2017 Apr 21; 292(16):6555-6568. PubMed ID: 28235801
    [Abstract] [Full Text] [Related]

  • 17. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
    Tanaka K, Osada H, Murakami-Tonami Y, Horio Y, Hida T, Sekido Y.
    Cancer Lett; 2017 Jan 28; 385():215-224. PubMed ID: 27773750
    [Abstract] [Full Text] [Related]

  • 18. NHERF1: molecular brake on the PI3K pathway in breast cancer.
    Georgescu MM.
    Breast Cancer Res; 2008 Jan 28; 10(2):106. PubMed ID: 18430260
    [Abstract] [Full Text] [Related]

  • 19. Alteration in the sensitivity to crizotinib by Na+/H+ exchanger regulatory factor 1 is dependent to its subcellular localization in ALK-positive lung cancers.
    Yang F, Hu M, Chang S, Huang J, Si Y, Wang J, Cheng S, Jiang WG.
    BMC Cancer; 2020 Mar 12; 20(1):202. PubMed ID: 32164629
    [Abstract] [Full Text] [Related]

  • 20. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
    Pan Y, Weinman EJ, Dai JL.
    Breast Cancer Res; 2008 Mar 12; 10(1):R5. PubMed ID: 18190691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.